Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

servier laboratories australia pty ltd - perindopril erbumine -

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 8mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 4mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 2mg

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 4mg/5mg milligram - perindopril and amlodipine

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 4mg/10mg milligram - perindopril and amlodipine

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 8mg/10mg milligram - perindopril and amlodipine

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate - perindopril apotex is indicated for: the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril apotex be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 4 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica - perindopril apotex is indicated for: the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril apotex be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 2 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; iron oxide red; lactose monohydrate; colloidal anhydrous silica - perindopril apotex is indicated for: the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril apotex be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.